Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quercus alba pollen
- Development stage
- Unknown
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intradermal, Percutaneous, Subcutaneous
01
Overview
Quercus alba pollen is a non-standardized, biologic allergen extract derived from the pollen of the white oak tree (Quercus alba). It is used for both the diagnosis and treatment of allergies to oak pollen. For diagnosis, it is administered via percutaneous or intradermal skin tests to determine a patient's sensitivity. For treatment, it is used in allergen immunotherapy, administered via subcutaneous injections in gradually increasing doses. This process aims to desensitize the patient's immune system, reducing the allergic response and symptoms of immediate hypersensitivity over time. The product is an injectable solution available from manufacturers like Greer Laboratories, Inc., and is intended for use by physicians experienced in managing allergic reactions.
- Other names
- white oak pollenwhite oak pollen extract
02
Targets
A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)
Beyond the preview
Go deeper on Quercus alba pollen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quercus alba pollen.